Patent · US Active

Crystal of a benzoxazinone compound

US8883780B2 · kind B2 · utility

0Cited by
3References
3Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 22, 2010
Grant dateNov 11, 2014
Priority date
Expiry dateDec 19, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a crystal of 2-(hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one useful as a preventive or therapeutic agent for obesity and the like. Specifically disclosed is a crystal of 2-(hexadecyloxy)-6-methyl-4H-3,1-benzoxazin-4-one having a powder X-ray diffraction pattern in which characteristic peaks appear at powder X-ray diffraction interplanar spacings (d) of around 16.54±0.2, 13.26±0.2, 4.70±0.2, 4.38±0.2, and 3.67±0.2λ.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.